Insider · CIK 0001569157

Gershkowitz Jayne

Reports to the SEC for 1 company · CRANBURY, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001569157

Forms 4 and 5

Insider transactions

27 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2015-07-01	AMICUS THERAPEUTICS, INC.M Exercise/Conversion	SVP, Chief Patient Advocate	MExercise/Conversion	+10.6K sh	$13.97	+$149K	16,342
2015-07-01	AMICUS THERAPEUTICS, INC.S Sale	SVP, Chief Patient Advocate	SSale	−10.6K sh	$13.97	−$149K	5,693
2015-07-01	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	SVP, Chief Patient Advocate	MExercise/Conversion	−4,374 sh	—	—	26,252
2015-07-01	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	SVP, Chief Patient Advocate	MExercise/Conversion	−3,463 sh	—	—	28,075
2015-07-01	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	SVP, Chief Patient Advocate	MExercise/Conversion	−2,812 sh	—	—	39,376
2015-06-01	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)A Award	SVP, Chief Patient Advocate	AAward	+50K sh	—	—	50,000
2015-05-11	AMICUS THERAPEUTICS, INC.S Sale	SVP, Chief Patient Advocate	SSale	−10K sh	$10.84	−$108K	5,693
2015-05-08	AMICUS THERAPEUTICS, INC.M Exercise/Conversion	SVP, Chief Patient Advocate	MExercise/Conversion	+25K sh	—	—	25,000
2015-05-08	AMICUS THERAPEUTICS, INC.F Tax Payment	SVP, Chief Patient Advocate	FTax Payment	−9,307 sh	$10.80	−$101K	15,693
2015-05-08	AMICUS THERAPEUTICS, INC.Restricted stock unitsM Exercise/Conversion	SVP, Chief Patient Advocate	MExercise/Conversion	−25K sh	—	—	25,000
2015-03-20	AMICUS THERAPEUTICS, INC.M Exercise/Conversion	SVP, Chief Patient Advocate	MExercise/Conversion	+10.6K sh	$11.51	+$123K	60,648
2015-03-20	AMICUS THERAPEUTICS, INC.S Sale	SVP, Chief Patient Advocate	SSale	−10.6K sh	$11.51	−$123K	50,000
2015-03-20	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	SVP, Chief Patient Advocate	MExercise/Conversion	−4,374 sh	—	—	30,626
2015-03-20	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	SVP, Chief Patient Advocate	MExercise/Conversion	−3,462 sh	—	—	31,538
2015-03-20	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	SVP, Chief Patient Advocate	MExercise/Conversion	−2,812 sh	—	—	42,188
2015-01-02	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)A Award	SVP, Chief Patient Advocate	AAward	+45K sh	—	—	45,000
2014-08-27	AMICUS THERAPEUTICS, INC.P Purchase	SVP, Chief Patient Advocate	PPurchase	+5,000 sh	$7.00	+$35K	55,000
2014-08-27	AMICUS THERAPEUTICS, INC.S Sale	SVP, Chief Patient Advocate	SSale	−5,000 sh	$7.00	−$35K	50,000
2014-08-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	SVP, Chief Patient Advocate	MExercise/Conversion	−5,000 sh	—	—	0
2014-08-25	AMICUS THERAPEUTICS, INC.P Purchase	SVP, Chief Patient Advocate	PPurchase	+5,000 sh	$6.00	+$30K	55,000
2014-08-25	AMICUS THERAPEUTICS, INC.S Sale	SVP, Chief Patient Advocate	SSale	−5,000 sh	$6.00	−$30K	50,000
2014-08-25	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	SVP, Chief Patient Advocate	MExercise/Conversion	−5,000 sh	—	—	5,000
2014-08-20	AMICUS THERAPEUTICS, INC.P Purchase	SVP, Chief Patient Advocate	PPurchase	+6,080 sh	$5.40	+$32.8K	56,080
2014-08-20	AMICUS THERAPEUTICS, INC.S Sale	SVP, Chief Patient Advocate	SSale	−6,080 sh	$5.40	−$32.8K	50,000
2014-08-20	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	SVP, Chief Patient Advocate	MExercise/Conversion	−6,080 sh	—	—	420
2014-01-03	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)A Award	SVP, Chief Patient Advocate	AAward	+45K sh	—	—	45,000
2013-06-18	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)A Award	SVP, Chief Patient Advocate	AAward	+35K sh	—	—	35,000

Recent filings

Accepted (ET)
Jul 14
AMICUS THERAPEUTICS INC0001209191-15-058117
SEC(opens sec.gov)
Jun 34
AMICUS THERAPEUTICS INC0001209191-15-049848
SEC(opens sec.gov)
May 124
AMICUS THERAPEUTICS INC0001209191-15-042022
SEC(opens sec.gov)
Mar 244
AMICUS THERAPEUTICS INC0001209191-15-029052
SEC(opens sec.gov)
Jan 304
AMICUS THERAPEUTICS INC0001209191-15-007994
SEC(opens sec.gov)
Aug 294
AMICUS THERAPEUTICS INC0001209191-14-055071
SEC(opens sec.gov)
Aug 264
AMICUS THERAPEUTICS INC0001209191-14-054452
SEC(opens sec.gov)

Companies

AMICUS THERAPEUTICS, INC.SVP, Chief Patient Advocate

Address

1 CEDAR BROOK DRIVE

CRANBURY, NJ, 08512